Single-Cell Transcriptome Analysis Reveals the Novel Subtypes and Therapeutic Implications of T-Lymphoid/Myeloid Mixed-Phenotype Acute Leukemia

表型 转录组 髓系白血病 髓样 生物 癌症研究 白血病 免疫学 医学 遗传学 基因 基因表达
作者
Ming Hong,Bin Huang,Wenjie Liu,Qian Sun,Jianyong Li,Sixuan Qian,Qianghu Wang,Kening Li
出处
期刊:Blood [Elsevier BV]
卷期号:144 (Supplement 1): 1549-1549
标识
DOI:10.1182/blood-2024-198791
摘要

Introduction: Mixed-phenotype acute leukemia (MPAL) is a rare and heterogeneous group of malignant diseases, accounting for 2%-5% of acute leukemia. MPAL can be further classified as B/myeloid (B/My), T/myeloid (T/My), rare types, acute leukemia of ambiguous lineage, not otherwise specified or acute undifferentiated leukemia based on the immunophenotype, according to the WHO criteria. The treatment of acute leukemia has seen significant advances over the last three decades, partly due to individualized treatment. However, clinical prognosis for MPAL patients is worse than both acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), with a 5-year survival rate of 47-75% in children and 20-40% in adults. Given the rarity of MPAL, historically poorly understanding in the pathogenesis and biology and a lack of prospective trial data to guide therapy, there are currently no established standard treatment guidelines for MPAL to date. The diversity in treatment sensitivity arises from the heterogeneity and unique molecular characteristics of malignant cells. Therefore, there is an urgent need to clarify the molecular subtypes of MPAL and identify potential therapeutic methods to provide personalized treatment strategies and improve the prognosis of the patients with MPAL. Methods: We conducted an in-depth analysis of single-cell transcriptome data from nearly 260,000 derived from the bone marrow of patients with AML, T-cell acute lymphoblastic leukemia (T-ALL), or T/myeloid MPAL, comparing these data with healthy donors. We employed various analytical methods, including cell subpopulation analysis, pseudotime analysis, cell type mapping, stemness evaluation, and functional enrichment analysis, to identify novel molecular subtypes associated with T/My MPAL. The findings were subsequently validated through external bulk transcriptome data and immunohistochemistry (IHC) staining. Furthermore, we assessed survival prognosis and drug sensitivity differences among patients with these subtypes. Results: Our study revealed that T/My MPAL malignant cells exhibited unique biphenotypic characteristics, significantly different from traditional AML or T-ALL. Although clinical differences between biphenotypic and bilineal T/My MPAL may exist, they were not significant at the whole transcriptome level. Using a topological manifold learning algorithm, we identified three subpopulations of MPAL malignant cells at the single-cell level, including AML-like, ALL-like, and a unique subpopulation that highly expressed the HOPX gene and exhibited higher stemness and quiescence. Notably, patients with a high prevalence of the unique subpopulation had significantly poorer prognosis. Additionally, we identified specific molecular markers for each subpopulation and validated these findings in multiple independent public datasets. Furthermore, we screened potential therapeutic drugs for each subtype, with venetoclax showing significant efficacy potential for the unique T/My MPAL subtype. Conclusions: Our research provided new insights into the molecular heterogeneity of MPAL and offered personalized diagnostic and therapeutic targets for patients. By identifying and validating different molecular subtypes and their specific markers, we screened potential therapeutic drugs for each subtype, with venetoclax showing promising therapeutic potential, particularly for patients with the unique T/My MPAL subtype. These findings are expected to improve the prognosis of MPAL patients and advance the development of personalized treatment strategies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
囧囧发布了新的文献求助10
刚刚
希望天下0贩的0的应助被Mely0203采纳,获得10
刚刚
xysama完成签到,获得积分10
刚刚
刚刚
熊猫海完成签到,获得积分10
1秒前
cc完成签到,获得积分10
1秒前
henry先森完成签到,获得积分10
1秒前
青年才俊发布了新的文献求助10
1秒前
标致青雪发布了新的文献求助10
1秒前
愉快的鞯完成签到,获得积分10
2秒前
悦耳凤灵的应助被欢喜若灵采纳,获得10
2秒前
2秒前
2秒前
CWJ发布了新的文献求助10
2秒前
ding的应助被zz采纳,获得10
2秒前
3秒前
3秒前
3秒前
熊猫海发布了新的文献求助10
4秒前
cc发布了新的文献求助30
4秒前
believe发布了新的文献求助10
5秒前
白云发布了新的文献求助10
5秒前
6秒前
淋湿巴黎发布了新的文献求助10
7秒前
情怀的应助被wyyyy采纳,获得10
8秒前
8秒前
9秒前
有你就足够完成签到,获得积分10
9秒前
上官若男的应助被xixi采纳,获得10
9秒前
xixi完成签到,获得积分20
9秒前
香蕉觅云的应助被xixi采纳,获得10
10秒前
科研通AI6.4的应助被王萍有采纳,获得10
11秒前
小y完成签到,获得积分10
11秒前
酷波er的应助被受伤白安采纳,获得10
11秒前
11秒前
红烧豆腐完成签到,获得积分10
11秒前
一杯芝士发布了新的文献求助10
12秒前
香蕉觅云的应助被yiyi采纳,获得10
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182178
求助须知:如何正确求助?哪些是违规求助? 9571839
关于积分的说明 21820273
捐赠科研通 7778694
什么是DOI,文献DOI怎么找? 3433632
关于科研通互助平台的介绍 2557802
邀请新用户注册赠送积分活动 2479657